Pune, India -- (SBWIRE) -- 09/28/2018 -- Global Anal Cancer Market – Overview
The anus is the opening at the end of the large intestine, below the rectum, where bowel movements leave the body. The beginning of the anal cancer is seen when the healthy cells grow in an uncontrolled manner, thereby, forming masses of cells called as tumours.
Global Anal Cancer Market -Key Players
Advaxis, Inc. (U.S.)
Taiwan Liposome Company, Ltd. (Twain)
These are the prominent players at the forefront of competition in the global anal cancer market and are profiled in MRFR Analysis.
Try Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/1530
The infected cells can be squamous cell, cloacogenic cell, anal lining cell and basal cell. A majority of the reported anal cancers are the squamous cell carcinomas. When the cells are at the beginning sate, they appears to be normal. This is the dysplasia state of the cancer.
Dysplasia in the anus is called anal intraepithelial neoplasia (AIN) or anal squamous intraepithelial lesions (SILs). Increasing prevalence of the anal cancer and sexually transmitted diseases along with the growing geriatric population are the major drivers for the market growth during the forecast period.
Global Anal Cancer Market – Growth and Analysis
In 2017, according to the American Cancer Society, 8,200 new cases of the anal cancer were reported in the U.S. causing 1,100 deaths.
According to the World Health Organization, the number of people aging 65 or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050, with most of the increase in developing countries.
The market is projected to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).
Global Anal Cancer Market- Competitive Analysis
Characterized by the presence of several well-established and small players, the global anal cancer market appears to be a highly competitive and fragmented market.
Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.
In August 2016, Amgen and Advaxis, Inc. entered into a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical investigational cancer immunotherapy treatment that is designed to activate a patient's immune system to respond against the unique mutations, or neoepitopes.
This collaboration brought together Amgen's development expertise in immuno-oncology with Advaxis' MINE program, which is uniquely positioned to develop a customized approach for cancer treatment.
In October-2017, Taiwan Liposome Company, Ltd. showcased the superiorities of its pain management solution at the Janney's Osteoarthritis and Pain Therapeutic Forum addressing company's TLC599 candidate.
Global Anal Cancer Market - Regional Analysis
The Americas leads the global anal cancer market due to a well-developed healthcare sector, huge patient population and rising healthcare expenditures within the region. Moreover, the presence of the global like Advaxis, Inc. within the region fuels the market growth during the forecast period.
The Americas is followed by Europe in the presence of the similar factors facilitating the market growth within the region. The Asia Pacific is the fastest growing region due to a huge patient population and continuously growing healthcare sector by the developing economies like India and China.
For Exclusive Discount Visit @ https://www.marketresearchfuture.com/check-discount/1530
Major Points form TOC for Anal Cancer Market Research Report – Forecast to 2027
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Anal Cancer Market, By Type
Chapter 7. Global Anal Cancer Market, By Treatment
Chapter 8 Global Anal Cancer Market, By End User
Chapter 9. Global Anal Cancer Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.